Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Gobburu

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Clinical Pharmacology and Therapeutics|June 22, 2016
Drugs Against Rare Diseases: Are The Regulatory Standards Higher?J Gobburu, D Pastoor
CPT: Pharmacometrics & Systems Pharmacology|June 15, 2016
Communicating to Influence Drug Development and Regulatory Decisions: A TutorialS Mehrotra, J Gobburu
Clinical Pharmacology and Therapeutics|May 15, 2009
Elucidation of relationship between tumor size and survival in non-small-cell lung cancer patients can aid early decision making in clinical drug developmentY Wang, C Sung, C Dartois, et al.
Clinical and Translational Science|May 13, 2016
Characterizing Class-Specific Exposure-Viral Load Suppression Response of HIV Antiretrovirals Using A Model-Based Meta-AnalysisY Xu, Y F Li, D Zhang, et al.
Clinical Pharmacology and Therapeutics|February 12, 2015
Optimizing oncology therapeutics through quantitative translational and clinical pharmacology: challenges and opportunitiesK Venkatakrishnan, L E Friberg, D Ouellet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2020
Model-based evaluation of the efficacy and safety of nivolumab once every 4 weeks across multiple tumor typesX Zhao, J Shen, V Ivaturi, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Clinical Pharmacology and Therapeutics|June 22, 2016
Drugs Against Rare Diseases: Are The Regulatory Standards Higher?J Gobburu, D Pastoor
CPT: Pharmacometrics & Systems Pharmacology|June 15, 2016
Communicating to Influence Drug Development and Regulatory Decisions: A TutorialS Mehrotra, J Gobburu
Clinical Pharmacology and Therapeutics|May 15, 2009
Elucidation of relationship between tumor size and survival in non-small-cell lung cancer patients can aid early decision making in clinical drug developmentY Wang, C Sung, C Dartois, et al.
Clinical and Translational Science|May 13, 2016
Characterizing Class-Specific Exposure-Viral Load Suppression Response of HIV Antiretrovirals Using A Model-Based Meta-AnalysisY Xu, Y F Li, D Zhang, et al.
Clinical Pharmacology and Therapeutics|February 12, 2015
Optimizing oncology therapeutics through quantitative translational and clinical pharmacology: challenges and opportunitiesK Venkatakrishnan, L E Friberg, D Ouellet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2020
Model-based evaluation of the efficacy and safety of nivolumab once every 4 weeks across multiple tumor typesX Zhao, J Shen, V Ivaturi, et al.
Pageof 1